Read the story here. Advertise at Before It's News here.
Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views
Last hour:
Last 24 hours:

NA Proactive news snapshot: CytoDyn, Evergold, Cloud Nine Education, Bam Bam Resources …

% of readers think this story is Fact. Add your two cents.

CytoDyn Inc (OTCQB:CYDY) said a Phase III trial of its leronlimab treatment, known as Vyrologix, for severe-to-critical patients with coronavirus (COVID-19) has demonstrated continued safety, a substantial improvement in the survival rate, and faster hospital discharge in critically ill COVID-19 patients. The biotechnology company said the trial data has been reported to the US Food and Drug Administration (FDA), the UK’s Medicines and Healthcare products Regulatory Agency (MHRA), and Health Canada (HC), and that it is in discussions with each regulator to determine the best path forward for the approval of leronlimab for the treatment of COVID-19 in the critically ill population.  A manuscript of the trial’s data is also being prepared and will be submitted for publication in one or more major medical journals. 

Evergold Corp (CVE:EVER) has revealed new high-grade gold and silver results from a sampling program on the Pyramid Peak area of its Snoball property in British Columbia (BC). Rock samples taken from the C Zone at Pyramid Peak included 23 grams per ton (g/t) gold and 309 g/t silver in one sample and 25.6 g/t gold and 750 g/t silver, while talus fines samples included 32.3 g/t gold and 53.8 g/t silver. The Toronto-based firm also released assays from the final hole of its 2020 Snoball drill campaign, which returned a high-grade gold intercept of 18.4 g/t gold and 5.6 g/t silver over 1.6 metres.

Cloud Nine Education Group Ltd (CSE:CNI) (OTCMKTS:CLGUF) has announced the launch of its new Education Technology Platform. In a statement Friday, the company said the move comes as part of a long-term strategy to partner with companies and technologies at the crossroads of education and emerging technologies. The premiere platform will target the education and stay-at-home sectors with selective learning modules and critical information.

Bam Bam Resources Corp (CSE:BBR) (OTCPINK:NPEZF) (FSE:4NPB) has told investors that recent and historic drill findings show the potential to “significantly” expand the known mineralization at its flagship Majuba Hill project in Nevada. Recent and historic holes at the asset in Pershing county “bottomed in significant copper grades below the copper oxide zones”, the firm said. The company highlighted one hole for example that was sunk to 1,100 feet (ft) and encountered an intercept of 370 feet at a grade of 0.45% copper (Cu) from between 730 and 1,100 ft in the enrichment zone.

KULR Technology Group Inc (OTCQB:KULR) said veteran manufacturing and operations executive Keith Cochran has joined the company as its president and chief operating officer. The developer of lithium-ion battery safety and thermal management technologies noted that Cochran brings over 25 years of successful operations and business management experience to the group, having previously served as senior vice president of Jabil Greenpoint’s global business units in Singapore.

Altamira Gold Corp (CVE:ALTA) (OTCPINK:EQTRF) (FRA:T6UP) said Monday it has confirmed four high-grade gold-silver vein structures at its Apiacas project in Brazil. In a statement, the Vancouver-based junior revealed that the veins appear to extend over at least a one-kilometre strike length on the Mutum target. Surface grab samples returned values of up to 403.5 grams per ton (g/t) gold, while recent channel samples included values of up to three metres at 10.4 g/t gold. Silver assays also returned high-grade values of up to 871 g/t. 

Orgenesis Inc (NASDAQ:ORGS) (FRA:45O) announced Monday it has signed a collaboration agreement with Dong-a University Hospital in South Korea and Cure Therapeutics Inc to utilize Orgenesis Mobile Processing Units and Labs (OMPULs). The company said the teams will align to use the OMPULs for point-of-care development of cell and gene therapies and immunotherapies that meet regulatory and governmental approval standards to scale through to commercialization. OMPULs are multi-purpose mobile autonomous good manufacturing practice (GMP) facilities intended to develop, optimize, and manufacture cell and gene therapies at the point of use. 

Alpine 4 Technologies Inc (OTCQB:ALPP) announced Monday that its subsidiaries Deluxe Sheet Metal Inc and Morris Sheet Metal Corporation are merging to become one of the largest sheet metal contractors in the Midwest region. Both companies will operate under the Morris Sheet Metal brand, and Deluxe and Morris are expected to be fully integrated by May 2021, Alpine 4 said in a statement. “This merger creates a more harmonious relationship between the two companies,” the company said. “The combining of resources empowers Morris to strengthen its brand through its strategic banking relationship, eliminate duplicative and competitive interests, and expand its footprint beyond the Indiana home base.”

QC Copper and Gold Inc (CVE:QCCU) (OTCMKTS:QCCUF) said Monday that drilling at its Opemiska project in Quebec was exceeding performance milestones and that it had hired a new independent director. As of March 8, 23 holes have been completed with a total of 5,125 metres (m) drilled and 1,907 samples sent to the lab for assaying, the company said. 

TechX Technologies Inc (CSE:TECX) (OTC:TECXF) (FRA:C0B) told investors Monday that its initial investment in the Canadian cryptocurrency exchange CatalX CTS Ltd has been an early success after it achieved significant growth in trading volume, daily users, deposits and revenue in February. Compared to January, trading volume more than tripled from about C$4 million to C$14.9 million in February. Monthly transactions jumped 2,281% from 1,012 to 24,091, while daily average users grew 75% from 16.41 to 28.64. Deposits tripled from C$1.2 million to more than C$4.6 million and revenue increased by 61% from $97,430 to $156,754. 

BetterLife Pharma Inc (CSE:BETR) (OTCQB:BETRF) (FRA:NPAU) has said it is partnering up with Carleton University in Ottawa to study TD-0148A – a second-generation LSD molecule – to treat depression. BetterLife reckons the therapy will mimic the projected therapeutic potential of LSD without causing undesirable psychoactive dissociative side effects. The university’s head of neuroscience Dr Argel Aguilar-Valles and his team will work with BetterLife to test TD-0148A in both in vitro and in vivo models in the lab in a bid to understand the molecular mechanisms that underlie psychiatric and neurodevelopmental disorders.

Empower Clinics Inc (CSE:CBDT) (OTCQB:EPWCF) (FRA:8EC) announced Monday that its KAI Medical Laboratory reached the milestone of 1,000 coronavirus (COVID-19) tests processed in one day last month and is now generating an annual revenue run rate of more than C$10 million. The company said it has seen specimen collection volumes grow in both January and February, with the latter delivering month-over-month growth of 27%. Additionally, the debut of Empower’s KAI Saliva PCR Test achieved an initial soft launch of 5,000 units, leading to an order of 25,000 additional units with a sales value of around C$5.5 million on January 7, the company said. It now anticipates placing an order for 50,000 additional KAI Saliva units with a retail sales value of around C$11 million to build inventory sufficient for the current demand in both the US and Canada.

Plurilock Security Inc (CVE:PLUR) (OTCQB:PLCKF) announced that it has expanded its direct sales team with the hiring of two new employees, including a US Armed Services veteran who has held cybersecurity and information technology leadership roles with companies such as BNY Mellon and JP Morgan Chase. Plurilock noted the new sales members will be tasked with executing numerous sales initiatives to promote the company’s cybersecurity offerings to companies in North America in order to grow Plurilock’s client base. “The expansion of our direct sales team represents an integral step for us to grow our North American client base,” Plurilock Security CEO Ian Paterson said in a statement.

Orogen Royalties Inc (CVE:OGN) (OTCMKTS:EMRRF) (FRA:5EV) has optioned its Ecru gold project, which lies in the prolific Cortez camp in Lander County, Nevada, US, to Australia’s first all-female-led resources company, Moneghetti Minerals Ltd. Moneghetti will be able to buy 100% of the asset over six years, by paying US$2.5 million in cash, and spending US$5 million on work. Upon earning all of it, it will grant a 2% net smelter return (NSR) royalty on 112 unpatented claims to Orogen. 

Benchmark Metals Inc (CVE:BNCH) (OTCQB:CYRTF) (FRA:87CA) has released more positive results from the Cliff Creek area at its flagship Lawyers project in British Columbia, which has extended the mineralized system there. Drilling at Cliff Creek South has hit broad zones of high-grade and bulk-tonnage mineralization, including 186 metres (m) at a grade of 1.34 grams per tonne (g/t) gold and 25.48 g/t silver or 1.66 g/t gold equivalent. 

Hillcrest Petroleum Ltd (CVE:HRH) (OTCQB:HLTRF) shares will soon be listed on the Canadian Securities Exchange as part of the company’s rebrand to Hillcrest Energy Technologies Ltd. The firm said Monday that it had received conditional approval from the CSE to list its shares under the ticker symbol ‘HEAT’. The moves are part of Vancouver-based Hillcrest’s plan to transition from a pure-play oil producer to a diverse clean energy technology company.

Algernon Pharmaceuticals Inc. (CSE:AGN) (FRA:AGW) (OTCQB:AGNPF), said it has increased and completed its previously announced non-brokered private placement of units raising gross proceeds of C$2,815,010. The clinical-stage pharmaceutical development company said it has issued an aggregate of 11,260,040 units at the price of C$0.25 each, with the net proceeds of the offering to be used to fund the company’s general corporate purposes.

Victory Resources Corporation (CSE:VR) (FRA:VR61) (OTCPINK:VRCFF) announced that it has completed its previously announced non-brokered private placement, raising proceeds of $622,800 through the sale of 8,304,001 units. The company said it intends to use the proceeds for general working capital, acquisitions and work programs on its existing exploration properties in Nevada and British Columbia, and any additional properties the company may acquire. Securities issued as a result of closing of the financing will be subject to a statutory hold period until July 9, 2021.

Phunware, Inc. (NASDAQ:PHUN), a fully-integrated enterprise cloud platform for mobile that provides products, solutions, data and services for brands worldwide, said it will be presenting at the 33rd Annual Roth Conference, which is being held virtually on March 15-17, 2021. Phunware said its management has recorded the presentation, which is available for replay here – – and will be attending one-on-one meetings throughout the conference. To receive additional information or to schedule a one-on-one meeting, please contact Phunware’s IR team at [email protected]

Medexus Pharmaceuticals Inc. (CVE:MDP) (OTCQX:MEDXF) (FRA:P731) has announced that Ken d’Entremont, its chief executive officer, and Roland Boivin, its chief financial officer will be conducting 1×1 meetings with investors during the 33rd Annual Roth Conference being held virtually from March 15–March 17, 2021. This year’s event will consist of 1-on-1/small group meetings, analyst-selected virtual fireside chats, thematic industry panels, and selected companies on-demand presentations. Institutional investors interested in one-on-one meetings with Medexus management should contact their ROTH Capital institutional sales representative.

Co-Diagnostics, Inc. (NASDAQ:CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, has announced that its CEO Dwight Egan will present at the 2021 H.C. Wainwright & Co. Global Life Sciences Conference, being held virtually on March 9-10. Participants can register for the conference via the following link: An archived version of the presentation can be accessed on the ‘Events and Webcasts’ section of the Co-Diagnostics website following the conclusion of the conference.

Lions Bay Capital Inc. (CVE:LBI) revealed Friday that on March 4, 2021, it acquired ownership of an additional 1,000,000 common shares of Fidelity Minerals Corp. (CVE FMN) at a price of $0.12 per share on the open market for consideration of $120,000. As a result of the acquisition, Lions Bay now owns a total of 22,380,312 Fidelity Minerals common shares, representing approximately 44.84% of the issued and outstanding common shares on an undiluted basis. It also owns warrants exercisable to acquire up to 10,815,583 Fidelity Minerals common shares which, if it were to exercise all of its warrants, it would then own 33,195,895 common shares of the Issuer, representing approximately 54.67% of the issued and outstanding shares. Lions Bay said the shares acquired will be held for investment purposes. “We are very excited by the potential of the gold properties held by Fidelity. Lions Bay has been instrumental in the restructuring and strengthening of Fidelity’s balance sheet. There is no doubt in our view, that two of the properties, Las Huaquillas and Las Brujas, are world-class, tier-one epithermal gold and porphyry targets,” said John Byrne, executive chairman of Lions Bay in a statement.

Story by ProactiveInvestors


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Please Help Support BeforeitsNews by trying our Natural Health Products below!

Order by Phone at 888-809-8385 or online at M - F 9am to 5pm EST

Order by Phone at 888-388-7003 or online at M - F 9am to 5pm EST

Order by Phone at 888-388-7003 or online at M - F 9am to 5pm EST

Humic & Fulvic Trace Minerals Complex - Nature's most important supplement! Vivid Dreams again!

HNEX HydroNano EXtracellular Water - Improve immune system health and reduce inflammation

Ultimate Clinical Potency Curcumin - Natural pain relief, reduce inflammation and so much more.

MitoCopper - Bioavailable Copper destroys pathogens and gives you more energy. (See Blood Video)
Oxy Powder - Natural Colon Cleanser!  Cleans out toxic buildup with oxygen! 
Nascent Iodine - Promotes detoxification, mental focus and thyroid health.
Smart Meter Cover -  Reduces Smart Meter radiation by 96%!  (See Video)

Immusist Beverage Concentrate - Proprietary blend, formulated to reduce inflammation while hydrating and oxygenating the cells.

Report abuse


    Your Comments
    Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

    Load more ...




    Email this story
    Email this story

    If you really want to ban this commenter, please write down the reason:

    If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.